z-logo
open-access-imgOpen Access
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19)
Author(s) -
Elizabeth M. Anderson,
Caroline Diorio,
Eileen C. Goodwin,
Kevin O. McNerney,
Madison E. Weirick,
Sigrid Gouma,
Marcus J. Bolton,
Claudia P. Arevalo,
Julie Chase,
Philip Hicks,
Tomaz B. Manzoni,
Amy E. Baxter,
Kurt P. Andrea,
Chakkapong Burudpakdee,
Jessica H. Lee,
Laura A. Vella,
Sarah E. Henrickson,
Rebecca M. Harris,
E. John Wherry,
Paul Bates,
Hamid Bassiri,
Edward M. Behrens,
David T. Teachey,
Scott E. Hensley
Publication year - 2020
Publication title -
journal of the pediatric infectious diseases society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.269
H-Index - 31
eISSN - 2048-7207
pISSN - 2048-7193
DOI - 10.1093/jpids/piaa161
Subject(s) - medicine , coronavirus , covid-19 , antibody , immunology , severe acute respiratory syndrome , severe acute respiratory syndrome coronavirus , respiratory system , disease , severity of illness , virology , infectious disease (medical specialty) , outbreak
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) antibody responses in children remain poorly characterized. Here, we show that pediatric patients with multisystem inflammatory syndrome in children (MIS-C) possess higher SARS-CoV-2 spike immunoglobulin G (IgG) titers compared with those with severe coronavirus disease 2019, likely reflecting a longer time since the onset of infection in MIS-C patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom